Healthcare - Sector
ADMA is currently covered by 4 analysts with an average price target of $17.25. This is a potential upside of $4.08 (30.98%) from yesterday's end of day stock price of $13.17.
ADMA Biologics's activity chart (see below) currently has 85 price targets and 73 ratings on display. The stock rating distribution of ADMA is 88.89% BUY and 11.11% HOLD.
Analysts' price targets on this stock were met 82.05% of the time, taking 988.82 days on average.
Highest price target for ADMA is $21, Lowest price target is $13, average price target is $17.25.
Most recent stock forecast was given by KRISTEN KLUSKA from CANTOR FITZGERALD on 05-Nov-2026. First documented stock forecast 09-Sep-2015.
Currently out of the existing stock ratings of ADMA, 8 are a BUY (88.89%), 1 are a HOLD (11.11%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 05-Nov-2026
$13
$-0.17 (-1.29%)
17 days ago
(05-Nov-2026)
10/11 (90.91%)
$-0.21 (-1.59%)
114
Buy Since 04-Jun-2019
$17
$3.83 (29.08%)
$20
4 months 7 days ago
(15-Jul-2026)
10/15 (66.67%)
$8.32 (95.85%)
582
Buy Since 10-May-2024
$21
$7.83 (59.45%)
$10
5 months 4 days ago
(18-Jun-2026)
1/2 (50%)
$12.69 (152.71%)
25
Buy Since 21-Apr-2026
$18
$4.83 (36.67%)
$21
6 months 15 days ago
(07-May-2026)
0/2 (0%)
$9.53 (112.51%)
Buy Since 07-Feb-2019
$26
$18
2 years 14 days ago
(08-Nov-2024)
19/20 (95%)
$3.38 (14.94%)
602
What is ADMA (ADMA Biologics) average time for price targets to be met?
Which analyst most recently updated their price target on ADMA (ADMA Biologics)?
Which analyst has the most public recommendations on ADMA (ADMA Biologics)?
Which analyst is the currently most bullish on ADMA (ADMA Biologics)?
Which analyst is the currently most reserved on ADMA (ADMA Biologics)?